GlassScriptPhysician profile
Joey L Trantham
NPI 1497774087
$22,170.94
in general payments reported to CMS, 2019-2025
34 companies · $294 in 2025
The $294 reported for 2025 was less than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17K · 2020: $1,587 · 2021: $727 · 2022: $646 · 2023: $1,650 · 2024: $703 · 2025: $294.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,763 · Travel and Lodging: $884.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,763.16 |
| Travel and Lodging | $884.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14,005.23 | 2019-2024 | Xarelto |
| Medical Device Business Services, INC. | $2,331.21 | 2019-2020 | |
| Medtronic, INC. | $1,534.63 | 2021-2024 | Symplicity G3, Crome Dr Mri Surescan |
| Novartis Pharmaceuticals Corporation | $448.77 | 2019-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $408.64 | 2019-2024 | Lifevest |
| Medtronic Vascular, INC. | $402.61 | 2019-2020 | |
| Boston Scientific Corporation | $383.91 | 2019-2024 | Watchman Access System, Watchman Flx |
| Amgen INC. | $321.59 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $290.48 | 2019-2025 | Eliquis, Camzyos |
| Merck Sharp & Dohme LLC | $267.90 | 2021-2023 | Verquvo |
| Sanofi-Aventis U.S. LLC | $257.67 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $181.11 | 2020-2023 | Jardiance |
| Amarin Pharma, INC. | $172.62 | 2019-2021 | |
| Chiesi USA, INC. | $150.21 | 2020-2022 | |
| Recor Medical INC | $135.61 | 2025 | Paradise Ultrasound Renal Denervation System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $117.30 | 2019-2021 | |
| Abbott Laboratories | $103.08 | 2020-2023 | Ensite |
| Bayer Healthcare Pharmaceuticals INC. | $102.67 | 2021-2025 | |
| Biosense Webster, INC. | $86.98 | 2024 | Carto 3 |
| Alnylam Pharmaceuticals INC. | $65.62 | 2021-2022 | |
| Philips North America LLC | $63.69 | 2023 | |
| Opsens INC. | $48.56 | 2020 | |
| Pfizer INC. | $45.81 | 2019-2025 | |
| Cardiovascular Systems INC. | $38.90 | 2019 | |
| Esperion Therapeutics, INC. | $37.78 | 2023-2024 | Nexletol |
| Shockwave Medical, INC | $25.78 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Siemens Medical Solutions USA, INC. | $25.16 | 2022 | |
| Actelion Pharmaceuticals US, INC. | $22.67 | 2022 | |
| Scpharmaceuticals INC. | $21.37 | 2024 | |
| Kiniksa Pharmaceuticals International, Plc | $20.26 | 2024 | Arcalyst |
| Astellas Pharma US INC | $17.52 | 2021 | |
| Inspire Medical Systems, INC. | $17.49 | 2025 | Inspire |
| Bardy Diagnostics, INC. | $12.00 | 2022 | |
| Cvrx, INC. | $6.11 | 2023 | Barostim Neo System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Trantham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.